Cellular Immune Responses to Human Papillomavirus (HPV)–16 L1 in Healthy Volunteers Immunized with Recombinant HPV‐16 L1 Virus‐Like Particles
Open Access
- 15 July 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 188 (2) , 327-338
- https://doi.org/10.1086/376505
Abstract
The causal association between papillomavirus (HPV) infection and cervical cancer has been demonstrated; the development of a prophylactic vaccine toKeywords
This publication has 4 references indexed in Scilit:
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 2011
- No one is naive: the significance of heterologous T-cell immunityNature Reviews Immunology, 2002
- Effect of Preexisting Neutralizing Antibodies on the Anti-tumor Immune Response Induced by Chimeric Human Papillomavirus Virus-like Particle VaccinesVirology, 2001
- ON IMMUNOLOGICAL MEMORYAnnual Review of Immunology, 1996